Dimitri Livitz
Dimitri Livitz
Verified email at - Homepage
Cited by
Cited by
Integrated genomic characterization of pancreatic ductal adenocarcinoma
BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ...
Cancer cell 32 (2), 185-203. e13, 2017
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
B Chapuy, C Stewart, AJ Dunford, J Kim, A Kamburov, RA Redd, ...
Nature medicine 24 (5), 679-690, 2018
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
M Sade-Feldman, YJ Jiao, JH Chen, MS Rooney, M Barzily-Rokni, ...
Nature communications 8 (1), 1-11, 2017
The evolutionary history of 2,658 cancers
M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ...
Nature 578 (7793), 122-128, 2020
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
VA Adalsteinsson, G Ha, SS Freeman, AD Choudhury, DG Stover, ...
Nature communications 8 (1), 1-13, 2017
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
P Polak, J Kim, LZ Braunstein, R Karlic, NJ Haradhavala, G Tiao, ...
Nature genetics 49 (10), 1476-1486, 2017
RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues
K Yizhak, F Aguet, J Kim, JM Hess, K Kübler, J Grimsby, R Frazer, ...
Science 364 (6444), eaaw0726, 2019
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
AR Parikh, I Leshchiner, L Elagina, L Goyal, C Levovitz, G Siravegna, ...
Nature medicine 25 (9), 1415-1421, 2019
Mitochondrial reprogramming underlies resistance to BCL-2 inhibition in lymphoid malignancies
R Guièze, VM Liu, D Rosebrock, AA Jourdain, M Hernández-Sánchez, ...
Cancer cell 36 (4), 369-384. e13, 2019
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
DA Landau, C Sun, D Rosebrock, SEM Herman, J Fein, M Sivina, ...
Nature communications 8 (1), 1-12, 2017
Pan-cancer analysis of whole genomes.
S Hirano, L Yang, M Juul, CA Purdie, BP O'Neill, R Kabbe, ...
Nature 578 (DKFZ-2020-01051), 82-93, 2020
Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in Hürthle cell carcinoma
RK Gopal, K Kübler, SE Calvo, P Polak, D Livitz, D Rosebrock, PM Sadow, ...
Cancer Cell 34 (2), 242-255. e5, 2018
Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair
NJ Haradhvala, J Kim, YE Maruvka, P Polak, D Rosebrock, D Livitz, ...
Nature communications 9 (1), 1-9, 2018
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
SC Dentro, I Leshchiner, K Haase, M Tarabichi, J Wintersinger, ...
Cell 184 (8), 2239-2254. e39, 2021
Growth dynamics in naturally progressing chronic lymphocytic leukaemia
M Gruber, I Bozic, I Leshchiner, D Livitz, K Stevenson, L Rassenti, ...
Nature 570 (7762), 474-479, 2019
Portraits of genetic intra-tumour heterogeneity and subclonal selection across cancer types
SC Dentro, I Leshchiner, K Haase, M Tarabichi, J Wintersinger, ...
BioRxiv, 312041, 2018
Comprehensive analysis of tumour initiation, spatial and temporal progression under multiple lines of treatment
I Leshchiner, D Livitz, JF Gainor, D Rosebrock, O Spiro, A Martinez, ...
biorxiv, 508127, 2019
FireCloud, a scalable cloud-based platform for collaborative genome analysis: strategies for reducing and controlling costs
C Birger, M Hanna, E Salinas, J Neff, G Saksena, D Livitz, D Rosebrock, ...
bioRxiv, 209494, 2017
Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens
PK Brastianos, N Nayyar, D Rosebrock, I Leshchiner, CM Gill, D Livitz, ...
NPJ precision oncology 1 (1), 1-8, 2017
The system can't perform the operation now. Try again later.
Articles 1–20